Literature DB >> 25126273

Patient cost-sharing on the rise: results from the benefit design index.

Melinda C Haren1, Kirk McConnell2.   

Abstract

OBJECTIVE: The relationship between healthcare insurers and employers plays a critical role today in decisions about benefit design, cost-sharing, and even the coverage of individual products and services. To better understand how these 2 stakeholders interact in the creation of healthcare benefit design, the Zitter Group conducted a large national study of insurer-employer relationship.
METHODS: This study is based on a primary web-based survey with 100 top decision makers in large national and important regional commercial managed care plans, and a similar survey of 100 employers and employer benefit consultants, including medical directors and benefit decision makers. This article reviews the results of this research, especially in relation to insurer and employer opinions on patient cost-sharing.
RESULTS: Findings from this study show that cost-shifting remains the prevailing cost-containment strategy used by insurers and employers. These stakeholders expect that additional cost-shifting will have minimal impact on patient health outcomes.
CONCLUSION: Despite accumulating evidence that cost-shifting leads to undesirable health and cost consequences and has largely failed to slow health cost growth, employers and insurers will likely continue to rely on this modality as their primary cost-containment strategy.

Entities:  

Year:  2009        PMID: 25126273      PMCID: PMC4115304     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  2 in total

1.  Evaluating ROI in state disease management programs.

Authors:  Thomas W Wilson
Journal:  State Coverage Initiat Issue Brief       Date:  2003-11

2.  As the health insurance underwriting cycle turns: what next?

Authors:  Joy M Grossman; Paul B Ginsburg
Journal:  Health Aff (Millwood)       Date:  2004 Nov-Dec       Impact factor: 6.301

  2 in total
  2 in total

1.  Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers.

Authors:  Melinda C Haren; Kirk McConnell; Arthur F Shinn
Journal:  Am Health Drug Benefits       Date:  2009-04

2.  Orphan drug pricing and payer management in the United States: are we approaching the tipping point?

Authors:  Rebecca Hyde; Diana Dobrovolny
Journal:  Am Health Drug Benefits       Date:  2010-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.